Tržište privatnog zdravstvenog osiguranja u debatama o reformi zdravstvenog sistema u postsocijalističkim zemljama / Private health insurance market in debates on the health system reform in postsocialist countries

Evropska revija za pravo osiguranja Vol. XX, No. 1 (2021), (стр. 55-62) 

АУТОР: Zdravko Šolak

Е-АДРЕСА: zdrsolak@yahoo.com.

Download Full Pdf   

DOI: 10.46793/ERPO2001.55S

САЖЕТАК:

Debate o reformi finansiranja zdravstvene zaštite u bivšim socijalističkim zemljama u periodu društvenog preobražaja vođene su u sklopu širih rasprava o promenama u ukupnom društvenom sistemu. Preispitivani su postojeći modeli finansiranja i razmatrane inovativne mere. U sklopu takvih rasprava deo pažnje privuklo je i tržište dobrovoljnog zdravstvenog osiguranja. U raspravama koje su tokom devedesetih godina prošlog veka vođene iznošeni su različiti stavovi, kako oni koji su u tom mehanizmu videli pogodan dopunski izvor finansiranja zdravstvene zaštite, tako i oni koji su u prvi plani isticali ograničenja koja se u njegovoj primeni javljaju i skromni rezultati koji se mogu očekivati. Kao jedan od kriterijuma za ocenu pogodnosti tog mehanizma moglo bi da posluži i ono što je do sada postignuto u njegovoj primeni. U radu se čini osvrt na pređeni put i stanje u bivšim socijalističkim zemljama pod kraj druge decenije ovog veka s posebnim osvrtom na Srbiju i zemlje u njenom okruženju.

КЉУЧНЕ РЕЧИ:

privatno zdravstveno osiguranje, Srbija, plaćanje „iz džepa”, nezarazne bolesti

ЛИТЕРАТУРА

  • Аистов, A., Aлександрова, E. (2018). Постконтрактный оппортунизм на рынке добровольного медицинского страхования, Экономическая политика, 13(3), 148–181.
  • Arentz, C., Ulrich, V. (2017). Entwicklung des GKV- Beitragssatzes in mittlerer und langer Frist (2030/2060): Mögliche
  • Pfade und Szenarien, Diskussionspapier 0417, Universität Bayreuth.
  • Baird, K. (2016). High out-of-pocket medical spending among the poor and elderly in nine developed countries, Health Services Research, 51(4), 1467–88.
  • Cashin, C. at al. (2014). Paying for Performance in Health Care Implications for health system performance and accountability, European observatory on health systems and policies, WHO, Open University Press, Berkshire.
  • Darvas, Z., at al. (2018). The macroeconomic implications of healthcare (No. 27000). Bruegel.
  • Gerry, C., Kaneva, M. and Zasimova, L. (2017). Reforming voluntary drug insurance in Russian healthcare: Does social solidarity matter? Health Policy, 121(11), 1177–1185.
  • Иванова, Е. В. (2011). Совершенствование форм инвестиционной деятельности на рынке медицинских товаров и услуг, МедицинскийвестникСеверногоКавказа, 22 (2), 79–81. Dostupno na:https://cyberleninka.ru, 10. 1. 2019.
  • Kutzin, J. (2008). Health financing policy: A guide for decision- makers. WHO, Regional office for Europe, Copenhagen.
  • Lefèvre, T. (2014). What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization, Revue d’Epidemiologie et de Sante Publique, 62, 305–314.
  • OECD (n/a).Glossary of statistical terms. Out-of-Pocket Expenditure by Households on Health. Dostupno na: https://stats. oecd.org/glossary/detail.asp?ID=1967, 10. 1. 2019.
  • Pauly, M. V. (1968). The Economics of Moral Hazard: Comment, American Economic Review 58, 531–537.
  • Powell, M. (2019). Seventy years of the British National Health Service: problem, politics and policy streams, Health economics, policy and law, 14, 29–39.
  • Rice, T., at al. (2018). Revisiting out-of-pocket requirements: trends in spending, financial access barriers, and policy in ten high-income countries, BMC health services research, 18(1), 371.
  • Sagan, A., Thomson, S. (2016).Voluntary health insurance in Europe: role and regulation. Copenhagen: WHO Regional Office for Europe.
  • Sum, G. at al. (2018). „Multimorbidity and out-of-pocket expenditure on medicines: a systematic review”, BMJ global health, 3(1).
  • Šolak, Z. (2010). „Razvojne perspektive tržišta privatnog zdravstvenog osiguranja”, Slavnić, J. Jovanović, S. (urednici) u: Evropske (EU) reforme u pravu osiguranja Srbije (284–296). Beograd: Udruženje za pravo osiguranja Srbije.
  • Thomson, S. etal. (2015). Economic crisis, health systems and health in Europe. Copenhagen: Open University Press, WHO/ European observatory on health systems and policies.
  • Тургамбаева, А. К., Ермуханова Л. С. (2017). Международный опыт применения страховой медицины: особенности ведущих стран мира, Вестник Казахского Национального медицинского университета, (4), 355‒360.
  • Ubel, P. A., Abernethy, A. P., Zafar, S. Y. (2013). Full disclosure out-of-pocket costs as side effects, New England Journal of Medicine, 369(16), 1484‒1486.
  • Zaimović-Šahman, M., Salihbegović-Šahman, S., Zver,(2018). „Analiza izvora finansiranja zdravstvenih sistema zemalja u sastavu bivše Jugoslavije”, Medicinski časopis, 52(2), 39‒55.
  • Wouters, J. O., McKee, M. (2017). Private Financing of Health Care in Times of Economic Crisis, Review of the Evidence, Global Policy, 8(2), 23‒29.
  • WHO. (2015). European Health for all database (HFA-DB) [online database]. Copenhagen: WHO Regional Office for Europe. http://data. euro.who.int/hfadb/.
  • WHO. (2019a). Global health expenditure database (GHED) [online database]. Geneva: WHO.(http://apps.who.int/nha/ database/Select/Indicators/en).
  • WHO. (2019b). European Health Information Gateway Estimated infant mortality per 1000 live births (world health report), https://gatewayeuro.who.int/en/indicators/hfa.
  • World Bank. (2019). World Development, Indicators. https:// databank.worldbank.org/ reports.aspx?source=2&series=SP. DYN.LE00; .INWHO.
  • Eurostat. (2019). https://ec.europa.eu/eurostat/tgm/table.do
  • ?tab=table&init=1&language=en&pcode=tps00027&plugin=1.